Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the USShruti Gupta, Jean-Sébastien Rachoin, Salim S. Hayek et al.|JAMA Internal Medicine|2020Cited by 1k
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19Shruti Gupta, Sushrut S. Waikar, Wei Wang et al.|JAMA Internal Medicine|2020Cited by 555
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United StatesJennifer E. Flythe, Samantha K. Brenner, Magdalene M. Assimon et al.|American Journal of Kidney Diseases|2020Cited by 234
Soluble Urokinase Receptor and Acute Kidney InjurySalim S. Hayek, Jochen Reiser, David E. Leaf et al.|New England Journal of Medicine|2020Cited by 204
Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidneyPetra Šimić, Eugene P. Rhee, Wondong Kim et al.|Journal of Clinical Investigation|2020Cited by 124